FluoroquinolonesAnti-Infective AgentsAza CompoundsLevofloxacinOfloxacinQuinolinesNaphthyridinesAdministration, OralMicrobial Sensitivity TestsCiprofloxacinDNA GyraseArea Under CurveAnti-Bacterial AgentsStreptococcus pneumoniaeDNA Topoisomerase IVQuinolonesMagnesium HydroxideDrug Resistance, BacterialOrnidazoleDrug Administration ScheduleAntibiotics, AntitubercularDose-Response Relationship, DrugMolecular ImprintingBacteria, AnaerobicMycobacterium fortuitumTyphoid FeverTime FactorsDrug CombinationsInjections, IntravenousPneumococcal InfectionsAluminum HydroxideUnited States Food and Drug AdministrationDrug Resistance, MicrobialIsoniazidDrug InteractionsMycobacterium chelonaeGram-Positive BacteriaAdministration, TopicalChromatography, High Pressure LiquidDisease Models, AnimalDrug Dosage CalculationsDrug Administration RoutesAntitubercular AgentsHalf-LifeCefiximeBacteriaBacteria, AerobicNepalTopoisomerase II InhibitorsRats, Sprague-DawleyPyrazinamideRifampinGram-Negative Aerobic BacteriaSalmonella paratyphi A4-QuinolonesMacrolidesStaphylococcus aureusEye Infections, BacterialPneumonia, BacterialAntacidsAdministration, IntranasalDNA Topoisomerases, Type IIRats, WistarBenzalkonium CompoundsDosage FormsCross-Over StudiesCeftriaxoneDrug Resistance, Multiple, BacterialRabbitsInjections, IntraperitonealTreatment OutcomeReserpineColony Count, MicrobialOphthalmic SolutionsDrug Therapy, CombinationThienamycinsClostridium difficileCephalosporinsEndophthalmitisDrug SynergismMeningitis, PneumococcalMonte Carlo MethodAqueous HumorMoraxella (Branhamella) catarrhalisInjections, SubcutaneousTreatment FailureAnthraxOxazolidinonesPiperacillinKetolidesMycobacterium tuberculosisAdministration, RectalLiverMice, Inbred C57BLClostridium InfectionsCommunity-Acquired InfectionsBiological AvailabilityLungErythromycinQuinidine